February 2012 | Oncology & Biotech News

March 23, 2012

Continuous treatment with lenalidomide given early prolonged the time to progression, compared with no treatment in patients with high-risk, asymptomatic, smoldering, multiple myeloma.

March 22, 2012

The Massachusetts General Hospital (MGH) Cancer Center comprises 23 fully integrated, multidisciplinary clinical programs, as well as an extensive array of support and educational services.

March 20, 2012

It may be possible to forgo radiation in previously untreated patients with limited-stage Hodgkin lymphoma.

March 20, 2012

Vorinostat added to bortezomib improved progression-free survival compared with bortezomib plus placebo in patients with relapsed/refractory multiple myeloma.

March 19, 2012

Patients with oropharyngeal squamous cell carcinoma who had matted lymph nodes -- nodes that are connected together -- are more likely to metastasize than those without matted lymph nodes.

March 19, 2012

Treatment with tivantinib produced a 56% improvement in time-to-progression in patients with hepatocellular carcinoma.

March 19, 2012

Contrary to earlier findings, surgical breast biopsies may not be as overused as previously thought, according to a recent study published in the Journal of the American College of Radiology.

March 14, 2012

The Trials in Progress section supplies summaries of ongoing research in a broad range of cancer types.

March 13, 2012

Acupuncture may help prevent xerostomia in patients with nasopharyngeal carcinoma undergoing radiotherapy and may also reduce symptom severity.

March 12, 2012

Treatment of selected cases of localized lymphoma during the second and third trimester was associated with minimal maternal and fetal risk of complications.

March 09, 2012

Clarient provides more than 350 diagnostic tests to assess and characterize tumors, including tests for BRAF, KRAS, and EGFR gene mutations.

March 09, 2012

The burden of late complications after hematopoietic cell transplantation is high, and these late effects are associated with poor health and decreased functional status.

March 08, 2012

Combination therapy with everolimus and the octreotide LAR increases the median PFS in patients with advanced neuroendocrine tumors associated with carcinoid syndrome.

March 07, 2012

A meta-analysis shows no apparent association between androgen deprivation therapy and cardiovascular events and death in men with prostate cancer.

March 05, 2012

A closer look at 2 investigational agents, carlfilzomib and pomalidomide, that were featured at the 53rd American Society of Hematology annual meeting.

February 29, 2012

New findings suggest that increased serum glucose levels may be a risk factor for colorectal cancer in postmenopausal women.

February 28, 2012

Annual prostate cancer screening does not decrease mortality from prostate cancer more than opportunistic screening.

February 28, 2012

The Miami Breast Cancer Conference has become a well-respected and well-attended gathering that specialists make a point of returning to year after year.

February 24, 2012

In 2011, the FDA reported 232 cancer therapies to be in limited supply. As a result, many patients have had therapies delayed or discontinued, and in some cases, patients have been left without access to appropriate alternatives.